Home/Filings/4/0001821825-25-000027
4//SEC Filing

WALSH MATTHEW M 4

Accession 0001821825-25-000027

CIK 0001821825other

Filed

May 5, 8:00 PM ET

Accepted

May 6, 1:59 PM ET

Size

4.5 KB

Accession

0001821825-25-000027

Insider Transaction Report

Form 4
Period: 2025-05-05
WALSH MATTHEW M
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2025-05-05$8.82/sh+11,400$100,548144,484 total

Issuer

Organon & Co.

CIK 0001821825

Entity typeother

Related Parties

1
  • filerCIK 0001269428

Filing Metadata

Form type
4
Filed
May 5, 8:00 PM ET
Accepted
May 6, 1:59 PM ET
Size
4.5 KB